CDKN2A and obesity disorder: Our study demonstrated that p16 knockout may alter β‐Alanine metabolism and pyrimidine metabolism in the kidney, which may suppress chronic renal inflammation, inhibit the NF‐κB pathway, and ultimately alleviate obesity‐related renal fibrosis.